204 related articles for article (PubMed ID: 15723172)
1. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.
Briolat J; Wu SD; Mahata SK; Gonthier B; Bagnard D; Chasserot-Golaz S; Helle KB; Aunis D; Metz-Boutigue MH
Cell Mol Life Sci; 2005 Feb; 62(3):377-85. PubMed ID: 15723172
[TBL] [Abstract][Full Text] [Related]
2. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
Preece NE; Nguyen M; Mahata M; Mahata SK; Mahapatra NR; Tsigelny I; O'Connor DT
Regul Pept; 2004 Apr; 118(1-2):75-87. PubMed ID: 14759560
[TBL] [Abstract][Full Text] [Related]
3. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.
Mahata SK; Mahata M; Wakade AR; O'Connor DT
Mol Endocrinol; 2000 Oct; 14(10):1525-35. PubMed ID: 11043569
[TBL] [Abstract][Full Text] [Related]
4. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity: involvement of new neuropeptides.
Metz-Boutigue MH; Kieffer AE; Goumon Y; Aunis D
Trends Microbiol; 2003 Dec; 11(12):585-92. PubMed ID: 14659691
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.
Lugardon K; Raffner R; Goumon Y; Corti A; Delmas A; Bulet P; Aunis D; Metz-Boutigue MH
J Biol Chem; 2000 Apr; 275(15):10745-53. PubMed ID: 10753865
[TBL] [Abstract][Full Text] [Related]
8. The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity.
Shooshtarizadeh P; Zhang D; Chich JF; Gasnier C; Schneider F; Haïkel Y; Aunis D; Metz-Boutigue MH
Regul Pept; 2010 Nov; 165(1):102-10. PubMed ID: 19932135
[TBL] [Abstract][Full Text] [Related]
9. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
[TBL] [Abstract][Full Text] [Related]
10. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery.
Mandalà M; Brekke JF; Serck-Hanssen G; Metz-Boutigue MH; Helle KB
Regul Pept; 2005 Jan; 124(1-3):73-80. PubMed ID: 15544843
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.
Tsigelny I; Mahata SK; Taupenot L; Preece NE; Mahata M; Khan I; Parmer RJ; O'Connor DT
Regul Pept; 1998 Oct; 77(1-3):43-53. PubMed ID: 9809795
[TBL] [Abstract][Full Text] [Related]
13. A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis.
Mahata SK; Mahata M; Yoo SH; Taupenot L; Wu H; Aroda VR; Livsey CV; Taulane JP; Goodman M; Parmer RJ; O'Connor DT
Adv Pharmacol; 1998; 42():260-4. PubMed ID: 9327894
[No Abstract] [Full Text] [Related]
14. The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses.
Mahata SK; Mahata M; Wen G; Wong WB; Mahapatra NR; Hamilton BA; O'Connor DT
Mol Pharmacol; 2004 Nov; 66(5):1180-91. PubMed ID: 15326220
[TBL] [Abstract][Full Text] [Related]
15. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules.
Taylor CV; Taupenot L; Mahata SK; Mahata M; Wu H; Yasothornsrikul S; Toneff T; Caporale C; Jiang Q; Parmer RJ; Hook VY; O'Connor DT
J Biol Chem; 2000 Jul; 275(30):22905-15. PubMed ID: 10781584
[TBL] [Abstract][Full Text] [Related]
16. Chromogranins: from discovery to current times.
Helle KB; Metz-Boutigue MH; Cerra MC; Angelone T
Pflugers Arch; 2018 Jan; 470(1):143-154. PubMed ID: 28875377
[TBL] [Abstract][Full Text] [Related]
17. Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin.
Mahata SK; Mahapatra NR; Mahata M; Wang TC; Kennedy BP; Ziegler MG; O'Connor DT
J Biol Chem; 2003 Aug; 278(34):32058-67. PubMed ID: 12799369
[TBL] [Abstract][Full Text] [Related]
18. The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.
Mahata SK; Mahata M; Livsey Taylor CV; Taupenot L; Parmer RJ; O'Connor DT
Adv Exp Med Biol; 2000; 482():263-77. PubMed ID: 11192587
[No Abstract] [Full Text] [Related]
19. Antimicrobial chromogranins and proenkephalin-A-derived peptides: Antibacterial and antifungal activities of chromogranins and proenkephalin-A-derived peptides.
Metz-Boutigue MH; Goumon Y; Strub JM; Lugardon K; Aunis D
Ann N Y Acad Sci; 2003 May; 992():168-78. PubMed ID: 12794056
[TBL] [Abstract][Full Text] [Related]
20. Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide.
Lugardon K; Chasserot-Golaz S; Kieffer AE; Maget-Dana R; Nullans G; Kieffer B; Aunis D; Metz-Boutigue MH
J Biol Chem; 2001 Sep; 276(38):35875-82. PubMed ID: 11451958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
